Upifitamab (Anti-SLC34A2)
Product Specifications
CAS Number
2254118-43-7
Target
Sodium Channel
Applications
Transmembrane Transporters
Additionnal Information
Upifitamab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize an ADC compound, Upifitamab rilsodotin, used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer. MW : 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040043-500 1x 500 µL
P21 / WAF1 (WA-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680012-100 1x 100 µL
Tyrosinase (T311), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682046-100 1x 100 µL
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681022-100 1x 100 µL
Hepatocyte Specific (CPS1/1022), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402970-100 1x 100 µL
MUC2 (Mucin 2) (MLP/2970R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882177-500 1x 500 µL
DNA Ligase 1 (1A9), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details